What are the causes and treatment options for pleural effusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Pleural Effusion

The most common causes of pleural effusion include heart failure (29%), malignancy (26%), pneumonia (16%), tuberculosis (6%), post-surgery (4%), pericardial diseases (4%), and cirrhosis (3%). 1

Classification of Pleural Effusions

Pleural effusions are broadly classified into two categories based on their pathophysiology:

Transudates

Transudates result from systemic factors that alter the hydrostatic or oncotic pressures:

  • Heart failure (accounts for >80% of transudates) 1
  • Liver cirrhosis (approximately 10% of transudates) 1
  • Hypoalbuminemia 1
  • Nephrotic syndrome 1
  • Atelectasis 1
  • End-stage renal failure (prevalence of 24.7% among ESRF patients) 1

Exudates

Exudates result from local factors affecting the pleura:

  • Malignancy (lung cancer most common, followed by breast cancer) 1
  • Parapneumonic effusions (pneumonia-related) 1
  • Tuberculosis 1
  • Pulmonary embolism 1
  • Rheumatoid arthritis (occurs in 5% of patients) 1
  • Systemic lupus erythematosus (affects up to 50% of patients during disease course) 1
  • HIV-related causes (Kaposi's sarcoma, parapneumonic effusions, tuberculosis) 1

Special Considerations for Specific Conditions

Malignant Pleural Effusions

  • Lung cancer is the leading cause of malignant pleural effusion 1
  • Breast cancer is the second most common cause 1
  • Lymphoma accounts for approximately 10% of malignant effusions 1
  • Multiple myeloma is an infrequent cause (about 6% of cases) with characteristically high pleural protein values 1

Autoimmune Diseases

  • Rheumatoid pleural effusions occur more commonly in men despite the disease affecting more women 1
  • Pleural fluid in rheumatoid arthritis typically has glucose <1.6 mmol/L (29 mg/dL) 1
  • SLE-related effusions may have LE cells in pleural fluid, which is diagnostic 1

HIV-Related Effusions

  • Leading causes in HIV patients: Kaposi's sarcoma (33%), parapneumonic effusions (28%), tuberculosis (14%) 1
  • Other causes include Pneumocystis carinii pneumonia (10%) and lymphoma (7%) 1

End-Stage Renal Failure

  • Causes include fluid overload (61.5%), heart failure (9.6%), and uraemic pleuritis 1
  • Unique causes in ESRF patients include urinothorax and peritoneal dialysis-associated pleuro-peritoneal leak 1

Persistent Undiagnosed Effusions

When the cause remains unclear after initial evaluation:

  • Reconsider pulmonary embolism and tuberculosis as they are amenable to specific treatment 1
  • Many undiagnosed effusions eventually prove to be malignant with sustained observation 1
  • Consider thoracoscopy if malignancy is suspected after routine tests have failed 1
  • A positive tuberculin skin test with an exudative lymphocytic effusion may justify empirical antituberculous therapy 1

Diagnostic Pitfalls to Avoid

  • Misclassification of cardiac and liver transudates as exudates occurs in 25-30% of cases 1
  • Pleural fluid ANA testing is not helpful in diagnosing SLE as it mirrors serum levels 1
  • Diagnostic bronchoscopy is not indicated unless the patient has hemoptysis or features of bronchial obstruction 1
  • Some conditions may cause either transudate or exudate (e.g., non-expansile lung, chylothorax, superior vena cava syndrome) 1

Incidental Pleural Effusions in Cancer Patients

  • Incidental findings of pleural effusion on chest radiographs are common (46%) 2
  • Asymptomatic effusions in cancer patients can be observed initially 2
  • Symptomatic effusions require thoracentesis to determine etiology 2
  • CT scan is indicated for better characterization of pleural effusion and underlying lung parenchyma 2

By systematically evaluating the clinical context and pleural fluid characteristics, the cause of pleural effusion can be determined in approximately 85% of cases, allowing for appropriate management strategies to be implemented. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Incidental Pleural Effusion in Cancer Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.